News
Discover the latest news and developments in AI and machine learning happening in the image-guided therapy (IGT) sector in Canada.
Seeing beneath the surface: How MIMOSA is transforming wound care
Dr. Karen Cross, a plastic and reconstructive surgeon and CEO of MIMOSA Diagnostics, saw countless patients with diabetes and chronic wounds in her clinic. People with diabetes have an increased risk of developing pressure wounds due to complications like poor circulation and nerve damage. Many of her patients came into her clinic too late to prevent complications and ultimately had lower extremity amputations to prevent fatal infections.
INOVAIT publishes framework for responsibly unlocking Canadian health data for innovation and better patient care
Industry members in the INOVAIT Network are developing AI technologies that are revolutionizing the diagnosis and treatment of disease and improving patient outcomes while building the Canadian healthcare economy. The health data these companies need to create their technologies most often reside with Canadian healthcare institutions that are reluctant to share data with commercial partners due to caution stemming from a lack of clarity in privacy legislation and historical practices focused primarily on minimizing privacy and security risks.
INOVAIT opens Pilot Fund program to support Canadian image-guided therapy and artificial intelligence projects
INOVAIT, the Canadian image-guided therapy (IGT) and AI network, is opening a call for applications for its Pilot Fund. The INOVAIT Pilot Fund is a reimbursement-based funding program to support collaborative research and development (R&D) projects that apply artificial intelligence, machine learning, or big data to IGT technologies.
Network News
A trailblazer in medical imaging: Terry Peters
Terry Peters, a New Zealander-Canadian with a background in Electrical Engineering from the University of Canterbury,...
How 16 Bit harnessed AI to prevent costly fractures, one X-ray at a time
As with many transformative businesses, 16 Bit came to be because of, sure, the brilliance and vision of its founders, but also a great deal of serendipity. 16 Bit might not exist had Dr. Mark Cicero and Dr. Alexander Bilbily not both chosen to pursue medical school (with backgrounds in engineering and computer science, respectively), had they not both decided to specialize in radiology, and had they not ended up in the same residency training program at the University of Toronto.
INOVAIT reveals Canada’s strategic advantages in image-guided therapy and artificial intelligence in latest report
INOVAIT, the pan-Canadian innovation network supporting advancements and commercialization in image-guided therapy (IGT) and artificial intelligence (AI), is excited to share their latest report titled, ‘Unlocking Medtech’s Potential: Canada’s Strategic Advantages in Image-Guided Therapy & AI’. Through synthesized insights from interviews with founders and executives from 30 IGT companies in the INOVAIT Network, this new report uncovers the untapped potential of the image-guided therapy sector in Canada.
INOVAIT and the Government of Canada announce the latest recipients of the INOVAIT Pilot Fund for advancements in image-guided therapy and artificial intelligence
INOVAIT, the pan-Canadian innovation network supporting advancements and commercialization in image-guided therapy (IGT) and artificial intelligence (AI), is excited to announce the latest recipients of its Pilot Fund. This competitive funding program is awarded to compelling medical technology projects that harness the transformative power of AI, machine learning, and big data analytics in IGT to advance medical innovation and streamline care.
IGT Lecture Series
Regulating AI in Image-Guided Therapy
Follow INOVAIT on Social Media
The Network in the Press
